|
Market Closed -
Saudi Arabian S.E.
12:35:29 06/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 64.80 SAR | +2.45% |
|
+5.88% | +1.98% |
| 06/11 | SNB Capital Cuts Avalon Pharma's PT, Confirms Neutral Rating | MT |
| 04/11 | Avalon Pharma's Q3 Attributable Net Profit, Revenue Rise | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 604M | - | - | - | - | - |
| 1,216B | |||||
| 656B | |||||
| 509B | |||||
| 384B | |||||
| 362B |
Select your edition
All financial news and data tailored to specific country editions
